Description
An orally available, non-peptidic inhibitor of MMP-2, MMP-3, and MMP-9 (Kis = 11, 143, and 301 nM, respectively); active in various animal models of tumor metastasis and has been used in a phase III clinical trial in pancreatic, SCLC, NSCLC, and ovarian cancer patients
Formal name: 4′-chloro-γ-oxo-αS-[(phenylthio)methyl]-[1,1′-biphenyl]-4-butanoic acid
Synonyms: BAY 12-9566
Molecular weight: 410.9
CAS: 179545-77-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Research Area|Cancer|Cell Migration & Metastasis||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases